COVER STORIES
Lab Medicine OutlookWhat Will the Coming Decade Bring?By Genna Rollins
The first decade of the 21st Century was a transformative for lab medicine, with many innovations and scientific advances. What will the next 10 years bring? CLN asked experts to reflect on the past and future of the field.
Test Reimbursement in 2010Why the Devil is in the DetailsBy Bill Malone
Despite the 4.5% increase to the lab fee schedule in 2009, experts are cautioning that labs should expect more scrutiny and belt tightening from the Center for Medicare and Medicaid Services in 2010. The 2010 fee schedule does include better payment for some tests; however, with CMS trying out new methods to audit and deny claims, labs will have to pay attention to the details and document carefully.
SERIES ARTICLE
Lyme DiseaseFinding the Balance of Diagnostic Testing and Clinical Disease FeaturesBy Glen T. Hansen, PhD, and Shulamith C. Bonham, MD
Diagnosis of Lyme disease remains difficult because clinical manifestations of the disease are easily confused with other illnesses. Laboratorians need to help clinicians understand the limitations of current testing methods when making a diagnosis.
NEWS BRIEF
Hospitals Face an Uncertain Financial Future
PATIENT SAFETY FOCUS
Lost Versus Misplaced SamplesImproving Lab Quality with Pull MeasuresBy Bonnie Messinger and Peggy Ahlin
Patient safety experts discuss methods to reduce the number of lost samples and improve overall lab performance.
To Err is HumanUsing Crew Resource Management to Reduce Errors in the LabAn Interview with James Hernandez, MD, MS
Crew resource management, a technique used to improve communication among team members, is now finding practical applications in healthcare and lab settings.
Mislabeled SpecimensWhen Should Relabeling of Mislabeled Specimens be Allowed? Should Relabeling be Noted in the Medical Record?Michael Astion, MD, PhD
A Q&A with a patient safety expert on how to ensure that samples are identified before they are processed by the lab.
PROFILES
Regulatory Profiles
Industry Profiles
Diagnostic Profiles
News from the FDA
Download the entire issue
The Outlook for the IVD Industry Emerging Biomarkers of Acute Renal Injury
The Outlook for the IVD Industry
Emerging Biomarkers of Acute Renal Injury